Change of Lymphocyte Subsets of HIV-Infected Asymptomatic Persons Administrated with Korean Red Ginseng.
- Author:
Byeong Sun CHOI
;
Yong Keun PARK
;
Mee Kyung KEE
;
Ok Hyun CHO
;
Yong Woo LEE
;
Yung Oh SHIN
- Publication Type:Original Article
- MeSH:
Asia;
HIV;
Humans;
Killer Cells, Natural;
Lymphocyte Subsets*;
Lymphocytes*;
Panax*;
Protease Inhibitors;
Reverse Transcriptase Inhibitors
- From:Journal of the Korean Society of Virology
1997;27(1):97-104
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
For 16 years after the finding of HIV as an agent of AIDS in 1981, HIV therapeutic drugs of reverse transcriptase inhibitors (AZT, ddI, ddC, d4T) and protease inhibitors have been developed. Recent studies also were focused on a combination therapy by using HIV therapeutic drugs or natural compounds. Korean red ginseng (KRG) of natural compounds has been well known as a good reinforcement agent in Asia. The percentage of CD3+CD4+ T cell in nine HIV-infected patients without KRG treatment averaged 17.8% on baseline and decreased 15.8% after 6 months, whereas the percentage of the cell in fifteen HIV-infected patients with KRG treatment averaged 15.3% on baseline and increased up to 18.9% after the same period. The average percentage of CD3+CD8+ T cell of KRG-nontreated and KRG-treated HIV patients increased after 6 months 47.8% to 50.7% and 44.7% to 51.4%, respectively; and the average percentage of B and NK cell in the KRG-nontreated and KRG-treated HIV patients decreased 9.4% to 7.9% and 13.0% to 9.7%, 8.9% to 8.5% and 16.2% to 11.6%, respectively, KRG, therefore, didn't have any effects on the CD3+CD8+ T cell, B cell, and NK cell. However, it seems that KRG has a potential activity for stimulating the
